Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study ...

Patients were given two daily treatments of oxytocin through nasal spray, every third day for six weeks by their care ...

They then used the nasal spray on several mouse models and observed them over time to see if it made a difference. The research team found that the mice exhibited reduced dementia symptoms.

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.

An anti-Alzheimer's nasal spray that could delay the progress of ... Alzheimer's is the most common form of dementia, and the leading cause of death among those aged 65 or older and afflicts ...

Scientists have developed a nasal Alzheimer's disease vaccine that ... but it is an accomplishment that can contribute to the development of a dementia cure," said team member Haruhisa Inoue ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...